NEUARTIGES BOTULINUMNEUROTOXIN UND DESSEN DERIVATE

Patent europeic · EP3481852 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3481852
Numer da la dumonda
EP17742898
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
07-07-2017
Publitgà
15-05-2019
Concedì
07-12-2022
La protecziun finescha il pli tard
06-07-2037
Proxima taxa annuala scadenta
31-07-2027
Classas IPC
C07K 14/33 (2006.01)
A61K 38/48 (2006.01)
C12N 5/00 (2006.01)
Prioritad
US 201662360239 P 08.07.2016
Dumonda PCT
PCT/US2017/041255 07.07.2017
Publicaziun PCT
WO2018/009903 11.01.2018
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-08-2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. 01-08-2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  3. 01-08-2024

    Midada

    Published in Swissreg on 01.08.2024

  4. 18-10-2023

    Midada

    Published in Swissreg on 18.10.2023

  5. 01-08-2023

    Midada

    Published in Swissreg on 01.08.2023

  6. 07-12-2022

    Concedì

    Published in Swissreg on 07.12.2022

Partidas

Possessur

Stenmark, Paul

10691 Stockholm, SE

CHILDREN'S MEDICAL CENTER CORPORATION

Children's Medical Center Corporation

55 Shattuck Street, Boston, MA 02115, US

Inventur

DONG, Min

Weatogue, CT 06089, US

STENMARK, Paul

10691 Stockholm, SE

ZHANG, Sicai

Boston, MA, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.